Sialylated HMO

3'-Sialyllactose Sodium Salt (3'-SL)

3'-Sialyllactose Sodium Salt gives technical teams a sialylated HMO option for advanced nutrition projects. Nutrition companies often review it with 6'-SL when they want a broader sialylated portfolio or a more complete HMO family range.

Nutrition companies usually review assay basis, sodium contribution, impurity profile, moisture, and microbiology before sampling or commercial formulation.

  • Sialylated HMO sodium salt for multi-HMO portfolio depth
  • Sodium contribution and residue indicators reviewed before sampling
  • Heat-stability and release-inspection support for formulation review
European scientist reviewing 3'-SL Sodium Salt nutrition samples in an application laboratoryFermentation-Based HMO
Molecular Formula
C23H38NO19Na
Relative Molecular Mass
655.53
HMO Family
Sialylated HMO
Appearance
White to off-white powder
CAS No.128596-80-5
MOQ10 kg
Shipping PortShanghai or Qingdao
Purity3'-SL water free, >=88.0%

Application and Regulatory Review

3'-SL Application, Use-Level, and Regulatory Review

Review 3'-SL application direction, use-level references, permitted categories, labelling points, and destination-market requirements before sampling, quotation, or commercial formulation.

Sialylated HMO Branch

3'-SL adds a sialylated structure to a portfolio that may already contain fucosylated and neutral HMOs. It is useful when the nutrition company wants a complete HMO-family story.

Immune-Response R&D Screening

The six-HMO comparison gives 3'-SL a clear R&D angle. We use it for screening and formulation discussion, not for disease prevention or treatment claims.

Specialty Nutrition and FSMP Review

3'-SL can be discussed for specialty nutrition projects where the target population, dosage, sodium contribution, and document requirements need careful review.

Pairing with 6'-SL

3'-SL pairs naturally with 6'-SL when nutrition companies want sialylated HMO coverage or a multi-HMO blend with acidic HMO components.

EU Novel Food Review

EU 2021/96 authorises 3'-SL sodium salt as a novel food, and EU 2024/1047 gives a newer source-specific 3'-SL sodium salt authorisation. Nutrition companies should also review same-day-use and age-group labelling requirements.

Use-Level Review Notes

  • FDA GRN 1299 lists 3'-SL sodium salt for non-exempt infant formula for term infants up to 0.28 g/L.
  • FDA GRN 1299 lists formula-type drinks for young children up to 0.28 g/L and other drinks for young children up to 0.15 g/L.
  • FDA GRN 1299 lists instant cereals for infants and young children up to 1.66 g/kg and other foods for infants and young children up to 1.25 g/kg.
  • EU entries for 3'-SL sodium salt show infant formula levels around 0.2 g/L to 0.28 g/L, depending on the authorised source.
  • EU follow-on formula entries show around 0.15 g/L to 0.28 g/L in final product ready for use.
  • EU food supplement entries include 0.5 g/day to 0.7 g/day, with restrictions for infants and young children.
  • Because this product is a sodium salt, include sodium contribution in the formulation review.

Technical Data

Specification Snapshot

3'-SL Specification

ColorWhite to off-white
AppearancePowder
3'-Sialyllactose Sodium Salt (Water-Free)>=88.0%
N-Acetylneuraminic Acid<=1.5%
3'-Sialyllactulose<=5.0%
D-Lactose<=3.0%
Moisture<=10.5%
Sodium<=4.2 x 10^3 mg/100 g
Residual Protein<=100 mg/kg
Endotoxins<=10 EU/mg
Total Arsenic<=0.1 mg/kg
Lead<=0.05 mg/kg
Total Plate Count<=500 CFU/g
Enterobacteriaceae<10 CFU/g
SalmonellaAbsent in 25 g

Specification Notes

Product Description
3'-Sialyllactose Sodium Salt (3'-SL) is a sialylated HMO sodium salt for advanced nutrition formulations that need acidic HMO coverage and sodium contribution review.
Storage Condition
Store at room temperature in sealed packaging. Keep dry and away from light.
Pack Size and Shelf Life
20 kg per carton or drum, packed as 10 kg x 2 bags. Shelf life: 24 months.
Packaging Material
Inner packaging uses food-grade PE bags and food-grade aluminum foil bags. Outer packaging uses a cardboard drum or carton.
Anticipated Use
For formulation review in children's milk powder, infant formula, older-infant and young-child formula, and infant formula for special medical purposes, subject to the destination market's authorization.

Project Support

Planning a 3'-SL or Multi-HMO Project?

Share your specification target, annual forecast, and market requirements. We will help check supply options, sample route, and application direction.